HaiKe Chemical Group's shares plummet on annual loss forecast

HaiKe Chemical Group said Friday it was likely to report an annual loss as weakened demand presented challenges for Chinese operations last year.

HaiKe Chemical Group said Friday it was likely to report an annual loss as weakened demand presented challenges for Chinese operations last year.

The China-based chemical and biochemical business said oil refineries were impacted by a sluggish economy for the year to December 31st.

A deterioration in market conditions affected trading in the last quarter, particularly in December, despite a strong start to the first half.

Tighter margins and lower utilisation rates in the refinery division also pushed down results.

The group's subsidiary Hebang was expected to report losses following a lower than forecast utilisation rate as a result of the change in the market for its first product Trichloroethylene, which suffered price drop and cost rise.

The second phase of construction at Hebang is ongoing and is expected to complete in March after which it will produce new products, namely caustic soda and epichlorohydrin, which are used to produce aluminium and epoxy resin respectively.

However, the company improved sales and marketing efforts in refined oil products, which helped HaiKe achieve record high group turnover.

Speciality, salt and biochemical divisions all recorded volume gains but prices fell in 2012.

HaiKe's gross margin halved in 2012 compared to the previous year as selling, general and administrative expenses surged due to enhanced marketing efforts.

"[Last year] was a difficult year for the refinery industry in China," said Xiaohong Yang, Executive Chairman.

"Despite the anticipated easing of the pricing mechanism, we expect the operating environment and domestic economy to remain challenging for refineries in the current year.

"The speciality/salt and biochemicals divisions, our core growth businesses, delivered a profitable performance and looking forward, the board remains focused on the company's long term growth by continuing to develop and expand its higher margin speciality chemicals which we believe will improve the profitability of the group."

Shares plunged 22.83% to 17.75p at 9:26 Friday.

RD

Recommended

Which assets will benefit as the “jam tomorrow” bubble pops?
Investment strategy

Which assets will benefit as the “jam tomorrow” bubble pops?

With tech stocks, cryptocurrencies and many other “long duration” investments crashing hard, the “jam tomorrow” bubble looks to be bursting. John Step…
24 Jan 2022
Three innovative Asian stocks to buy now
Share tips

Three innovative Asian stocks to buy now

Professional investor Fay Ren of the Cerno Pacific Fund highlights three of her favourite Asian stocks to buy now
24 Jan 2022
Share tips of the week – 21 January
Share tips

Share tips of the week – 21 January

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
21 Jan 2022
Seven cheap defence stocks to buy now
Share tips

Seven cheap defence stocks to buy now

We’ve got used to a world without war between major powers, but that era is coming to an end as Russia threatens Ukraine and China eyes Taiwan. Buy de…
21 Jan 2022

Most Popular

Shareholder capitalism: why we must return power to listed companies’ ultimate owners
Investment strategy

Shareholder capitalism: why we must return power to listed companies’ ultimate owners

Under our system of shareholder capitalism it's not fund managers, it‘s the individual investors – the company's ultimate owners – who should be telli…
24 Jan 2022
Three innovative Asian stocks to buy now
Share tips

Three innovative Asian stocks to buy now

Professional investor Fay Ren of the Cerno Pacific Fund highlights three of her favourite Asian stocks to buy now
24 Jan 2022
Ask for a pay rise – everyone else is
Inflation

Ask for a pay rise – everyone else is

As inflation bites and the labour market remains tight, many of the nation's employees are asking for a pay rise. Merryn Somerset Webb explains why yo…
17 Jan 2022